Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big ...

Goldman Sachs initiated coverage of Silence Therapeutics (SLN) with a Sell rating and $6 price target The company is developing siRNA ...

OliX and Eli Lilly announced a global licensing agreement, focusing on the development and commercialization of OliX’s ...

We find diamonds in the rough and we cut and finish them,' Roquefort boss Ajan Reginald says, summing up the company's ...

WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA – a genetically validated target that provides a new approach for healthy, ...

Martin Luutar Kiing seena siyaasaa US keessatti nama mallattoo falmaa mirga dhala namaa ta'edha, garuu seenaansaa qixa sirrii ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA - a genetically validated target that provides a new approach for healthy, sustainable weight loss (fat loss with muscle preservation) ...

LONDON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, announced today that it will ...

Showers like Aniston's can improve circulation, reduce stress, and improve skin health – these luxury features are changing ...